Media contact: Kristie Foster, Executive Director
Email: Kristie.Foster@USOncology.com
Phone number: 405.312.3038
SCRI Oncology Partners Welcomes Hans Lee, MD, and Cody Lebeck Lee, MD to Provide Expert Cancer Care to Tennessee Community
With these new physician additions, SCRI Oncology Partners continues to commit to providing high-quality cancer care to the community.
Nashville, Tenn. [06.01.25]—SCRI Oncology Partners, a dedicated cancer treatment center led by globally recognized oncology experts, is proud to welcome Hans Lee, MD, and Cody Lebeck Lee, MD to the practice. Both physicians bring a high level of expertise to the practice’s comprehensive cancer treatment options.
“By adding these renowned experts to our physician team, we continue our commitment to transforming cancer care by offering leading-edge treatment options and the latest cancer advancements to the greater Tennessee area,” said David Spigel, medical oncologist at SCRI Oncology Partners and chief scientific officer of Sarah Cannon Research Institute (SCRI). “We continue to expand our team of highly trained and committed physicians as we are dedicated to bringing world-class care to our community.”
Dr. Hans Lee received his undergraduate degree from Purdue University and his Doctor of Medicine degree from Indiana University School of Medicine. He then went on to a residency at Washington University School of Medicine/Barnes-Jewish Hospital and a clinical fellowship where he was the Chief Hematology Fellow at the University of Texas MD Anderson Cancer Center. He is board-certified in internal medicine, hematology and oncology, with a dedicated clinical interest in treating myeloma.
An active contributor to the advancement of cancer care, Dr. Hans Lee’s research has been highlighted in 125+ peer-reviewed publications and abstracts. In addition to his practice at SCRI Oncology Partners, Dr. Hans Lee joins SCRI as the Director of Myeloma Research.
Dr. Cody Lee is a medical oncologist and hematologist at SCRI Oncology Partners. He received his medical degree from the University of California Davis before completing a residency in internal medicine at the University of Cincinnati Medical Center. Dr. Cody Lee then turned his focus to cancer care, completing a fellowship in oncology and hematology at Vanderbilt University Medical Center. While completing his fellowship, he participated in multiple clinical research projects contributing to the advancement of care.
SCRI Oncology Partners is located at 335 24th Avenue North, Suite 200 in Nashville. To make an appointment, call 615-329-7640 or visit CancerCareSCRI.com.
About SCRI Oncology Partners
SCRI Oncology Partners is a leading cancer treatment center located in Nashville, Tennessee. Led by an elite team of globally recognized oncologists with specialized disease and clinical research expertise, this center offers patients state-of-the-art personalized cancer care and opportunities to participate in innovative clinical trials. Currently, there are more than 260 studies open for enrollment for all stages of cancer, with a significant pipeline of studies to open soon. SCRI Oncology Partners conducts clinical trials through a collaboration with Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI has contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade.
About The US Oncology Network
SCRI Oncology Partners is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 2,600 independent physicians dedicated to delivering value based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices.